Ministry of Food and Drug Safety, 30 days for clinical trial approval → shortened to 7 days and 15 days
The world’s first autologous stem cell treatment for degenerative arthritis’Jointstem’ completes the follow-up of a patient in phase 3 clinical trial in Korea. Trinity Medical News
![[약업신문]Nature Cell completes all patient follow-up in JointStem Phase 3 clinical trials](http://www.yakup.com/images/common/yakup.jpg "[약업신문]Nature Cell completes all patient follow-up in JointStem Phase 3 clinical trials")
